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Methods: All consecutive patients admitted for HF in the cardiology department 
of the Rouen University Hospital between July and August 2012 were enrolled in the 
study and randomized into two groups (control and POCKET). They all had baseline 
cardiac function assessment in the days following their admission using standard 
echocardiography. The POCKET group had early echocardiogram performed using 
the ultra-portable device at bedside within 48 hours after admission. We evaluated 
the length of hospitalization in both groups as well as reliability of ultrasonography 
using the ultra-portable device as compared to usual echocardiography.
Results: 62 patients were enrolled in our study, 32 patients in the POCKET 
group and 30 in the control group. There was a trend toward length of hospitali-
zation reduction in the POCKET group compared to the control group (6.8±5.2 
days vs 8.4±5.4 days, p=0.09). However, we have demonstrated the feasibility 
and reliability of the use of ultra-portable echocardiograph by two operators, a 
junior and a senior, as compared to a reference standard echocardiogram (ER), 
over a high-end device, carried out by a trained operator. Correlations between 
left ventricular ejection fractions estimated (junior/senior: r2=0.76; junior/ER: 
r2=0.75, senior/ER: r2=0.79) as well as concordance of other echocardiographic 
parameters were satisfactory.
Conclusions: Ultra-portable ultrasound allows early and reliable evaluation of 
cardiac function by a junior MD in patients hospitalized for heart failure, and its use 
tends to reduce the length of hospitalization.
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Usefulness and reliability of POCKET ultrasound in assessing cardiac 
function in patients hospitalized for heart failure in a cardiology department
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Objective: The median length of hospitalization for heart failure (HF) in France is 13 
days and admissions are the main cost of this common and severe disease. The development 
of ultra-portable ultrasound equipment (POCKET) enables early assessment of cardiac 
function at the bedside. We evaluated the use of this new tool and its impact on the length 
of hospital stay in patients with HF.
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Results: Compared to control, SCD had signifi cant higher left ventricular 
diastolic diameter indexed to body surface area (LVEDDind), left atria diameter 
indexed (LADind), CI, and lower LVEF. Systolic pulmonary artery pressure (sPAP) 
was not different between the two last groups. In SCD, LVEF was not correlated with 
Hb (p=0.74) whereas CI and LVEDDind were (both R: 0.25, p<0.0001). Systolic 
dysfunction (LVEF<50%) was observed in only 3.4%. There was poor relationship 
between LVEDD and CI (R=0.15, p=0.01). Patients were divided in quartiles of CI 
and LVEDDind. Patients in the fourth quartiles (Q4) of LVEDDind (median/range: 
35 (34; 37)) and of CI (4.7 (4.5; 5.3)) versus the three others quartiles (Q1-3) had 
signifi cantly lower Hb, HbF and RBC and higher lactate dehydrognease and bilirubin 
which are associated with hemolysis. Patients in Q4 LVEDDind had lower heart rate, 
LVEF and higher CI, LADind, sPAP, severity of mitral regurgitation, compared to 
Q1-3. Patients in Q4 CI had higher heart rate, LVEDDind, LADind, sPAP, and lower 
E/A compared to Q1-3. Determinants of Q4 LVEDDind and CI using multivariate 
binomial regression analysis were respectively lower Hb and HbF and lower RBC 
and HbF. Patients with alpha-thalassemic one or two gene deletions had less severe 
anemia and signifi cant lower cardiac remodeling CI.
Conclusion: In SCD, cardiac remodeling and elevated cardiac output are 
determined by hematologic variables and associated with hemolytic pattern. 
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Does the lack of late gadolinium enhancement using magnetic resonance 
imaging eliminate coronary artery disease in patients presenting with systolic 
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Background: Coronary artery disease (CAD) usually diagnosed through coronary 
angiogram. Magnetic resonance imaging (MRI) is a non invasive exam detecting 
myocardial damage resulting from CAD. Little is known regarding the value of MRI 
late gadolinium enhancement (LGE) in diagnosing CAD in case of systolic heart failure. 
Aims: To evaluate whether the lack of late gadolinium enhancement eliminates 
CAD in new onset systolic heart failure.
Methods: From February 2005 to March 2010, 81 patients presenting with 
new onset heart failure and left ventricular ejection fraction ≤35% were included. 
Patients had to have no clinical, electrical or biological evidence of CAD and to have 
undergone both coronary angiogram and cardiac MRI. CAD was defi ned by the 
presence of coronary stenosis ≥50%. Only transmural or sub-endocardial LGE-MRI 
were considered. Negative predictive value of LGE-MRI for the diagnosis of CAD 
was assessed. 
Results: Sixty-one patients (75.3%) patients did not present any LGE-MRI. 
Seventeen patients (21%) suffered from CAD. Out of the 61 patients with no LGE-MRI, 
60 (98.3%) were CAD-free. The single patient with CAD free of LGE had a 60% 
stenosis of the distal right coronary artery. Out of the 20 patients with LGE-MRI, 16 
(80%) were diagnosed with CAD. 
Conclusion: In new onset heart failure with both left ventricular dysfunction ≤35% 
and unexpected CAD, the lack of LGE-MRI eliminated 98.3% of CAD. MRI could 
be an attractive alternative in this setting. 
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Oxidative stress, mitochondrial and cardiac dysfunction after nitrogen 
dioxide (NO2) exposure in rat heart
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Christelle Monteil
EA 4651 ABTE-ToxEMAC, Rouen, France
Adverse cardiovascular effects of diesel engine exhaust (Diesel) have been extensively 
studied and it is now well accepted that exposure to particulate matter (PM) air pollution 
contributes to cardiovascular morbidity and mortality. However, other pollutants such as 
NO2 could also be involved in Diesel-induced health effects. Indeed, the exhaust catalysts 
increase the levels of NO2 markedly, although total NOx remains essentially the same. 
NO2 is a well-known oxidant molecule, however its role in Diesel-induced cardiovascular 
effects remains unknown. In this work, we hypothesized that NO2 may lead to altered 
mitochondrial function that in turn may cause left ventricular dysfunction. Wistar rat 
hearts were exposed by the technique of isolated perfused heart to NO2 (5 ppm) directly 
bubbled into the perfusion fl uid. Cardiac function was evaluated by recording coronary 
blood fl ow, heart rate and contractility. After cardiac function assessments, cardiac 
mitochondrial parameters were evaluated from isolated mitochondria (subsarcolemmal, 
SSM, and interfi brillar, IFM) to assess the mitochondrial reactive oxygen species (ROS) 
by electron paramagnetic resonance and the ATP production by luminometry. Finally, 
respiratory parameters of the total mitochondrial population were studied in situ in 
saponin-permeabilized fi bers isolated from LV.
NO2 exposure induced a functional alteration of the myocardium by a rapid and 
signifi cant decrease in coronary fl ow, heart rate and contractility parameters. NO2 
is also responsible for the development of mitochondrial dysfunction by decreasing 
respiration in the permeabilized fi bers, and by decreasing ATP production and increasing 
ROS production, specifi cally in IFM. Taken together, these results demonstrate that 
NO2 induced a cardiac dysfunction and a mitochondrial defect, suggesting that NO2 
may contribute to the Diesel-induced cardiovascular effects.
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Hematologic determinants of cardiac remodelling and cardiac index in 
sickle cell disease patients
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Background: In sickle cell disease (SCD), relationship between cardiac remode-
ling, cardiac index(CI) and haemoglobin (Hb), red blood cell count (RBC) and foetal 
hb (HbF) have not been well characterized.
Methods: We interrogated our hospital database including 1780 SCD patients. 
Inclusion criteria were: patients with SS or ST SCD without pregnancy and having 
an echocardiography and hemogram. 656 SS-ST were included in the analysis with 
a mean age of 31(25; 40). SCD patients were compared with 25 age-matched healthy 
black subjects. Echocardiography included M-mode, 2D, and pulsed Doppler.
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for facilitated large scale HF screenings are required. Indeed, 30 % of the patients 
admitted to emergency care for acute dyspnea have a BNP concentration in a “grey 
zone” that do not allow for diagnosis. Thus, diagnosis of these patients is costly and 
time-consuming while a rapid medical care of the patient has a positive impact on 
his health and reduces the treatment cost. 
Therefore, we have launched a prospective monocentric case-control study and 
investigated for urinary polypetides specifi c to acute (AHF) or chronic heart failure 
(CHF), using a capillary electrophoresis-mass spectroscopy strategy (CE-MS). Based 
on a screen of the urinary proteome of 80 patients (CHF, AHF, and healthy controls 
matched for cardiovascular risk factors), we revealed a panel of polypeptides specifi c 
to HF. One polypeptide (X64054) seemed very relevant because it could discriminate 
AHF and CHF with a high specifi city and specifi city (AUC=0.99; p<0,0001). X64054 
was validated with plasma samples from one cohort from Atlanta (n=340, follow-up 3 
years). This cohort revealed that X64054 level is associated with major clinical events: 
HR: 1.23 per 100 ng/mL (95% CI: 1.06 to 1.43); p=0.005 and with HF admissions: 
IRR: 1.20 per 100 ng/mL (95% CI: 1.00 to 1.44); p=0.05. 
We now aim at the validation of these putative biomarkers in another study 
enrolling 200 patients (50 per group), comprising 50 with a BNP level in the “grey 
zone”. Our work should provide with new biomarkers allowing for HF diagnosis in 
the BNP “grey zone” and therefore allow for a better care of the HF patients at the 
hospital but also in general care. 
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Blood heart failure (HF) biomarkers such as the natriuretic peptides (NP) are 
widely used but the NP biomarker family has limitations and HF diagnosis remains 
too often complicated because of atypical presentations and the need of specialized 
care access. More specifi c and accurate biomarkers with detection method allowing 
